CXCL8, C-X-C motif chemokine ligand 8, 3576

N. diseases: 1254; N. variants: 10
Source: ALL
Disease Type Disease Class Semantic Type N. genes d N. SNPs d Score gda EL gda EI gda N. PMIDs N. SNPs gda First Ref. Last Ref.
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
phenotype Neoplastic Process 6626 169 0.100 None 0.986 138 1995 2020
Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site
disease Disease or Syndrome 593 24 0.100 None 1.000 77 1995 2020
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site
disease Disease or Syndrome 467 14 0.100 None 0.964 28 1991 2019
CUI: C1411966
Disease: Clostridium; difficile (disorder)
Clostridium; difficile (disorder)
disease Disease or Syndrome 106 0.100 None 1.000 21 2006 2019
Malignant neoplasm of colon and/or rectum
disease Neoplastic Process 3669 502 0.100 None 1.000 20 2009 2019
Human immunodeficiency virus (HIV) II infection category B1
disease Disease or Syndrome 985 56 0.100 None 1.000 10 1999 2017
CUI: C2062441
Disease: Influenza A
Influenza A
disease Disease or Syndrome 563 19 0.070 None 1.000 7 2002 2019
CUI: C0521158
Disease: Recurrent tumor
Recurrent tumor
phenotype Neoplastic Process 735 33 0.060 None 1.000 6 2008 2017
CUI: C4290046
Disease: trachomatis
trachomatis
disease Disease or Syndrome 175 7 0.060 None 0.833 6 2001 2017
Chronic rhinosinusitis with nasal polyps
disease Neoplastic Process 168 1 0.060 None 0.833 6 2014 2020
estrogen receptor-negative breast cancer
disease Neoplastic Process 356 40 0.060 None 1.000 6 2003 2019
CUI: C0278488
Disease: Carcinoma breast stage IV
Carcinoma breast stage IV
disease Neoplastic Process 573 14 0.050 None 1.000 5 2003 2019
CUI: C0334037
Disease: Intestinal metaplasia
Intestinal metaplasia
phenotype Disease or Syndrome 266 24 0.040 None 1.000 4 2008 2012
androgen independent prostate cancer
disease Neoplastic Process 190 5 0.040 None 1.000 4 2000 2009
CUI: C1739135
Disease: Progression of prostate cancer
Progression of prostate cancer
disease Neoplastic Process 398 7 0.040 None 0.750 4 2004 2018
CUI: C1868683
Disease: B-CELL MALIGNANCY, LOW-GRADE
B-CELL MALIGNANCY, LOW-GRADE
disease Neoplastic Process 350 19 0.040 None 1.000 4 1994 2007
CUI: C1962942
Disease: TRICHOMONAS VAGINALIS (finding)
TRICHOMONAS VAGINALIS (finding)
disease Disease or Syndrome 56 0.040 None 1.000 4 1995 2019
CUI: C2363741
Disease: HIV-1 infection
HIV-1 infection
disease Disease or Syndrome 695 94 0.040 None 0.750 4 2002 2018
Oestrogen receptor positive breast cancer
disease Neoplastic Process 510 58 0.040 None 1.000 4 2003 2019
CUI: C3714948
Disease: PACHYONYCHIA CONGENITA 3
PACHYONYCHIA CONGENITA 3
disease Disease or Syndrome 209 20 0.040 None 1.000 4 2014 2019
CUI: C0280220
Disease: stage, ovarian epithelial cancer
stage, ovarian epithelial cancer
disease Neoplastic Process 65 0.030 None 0.667 3 2000 2020
CUI: C0856169
Disease: Endothelial dysfunction
Endothelial dysfunction
phenotype Disease or Syndrome 716 25 0.030 None 1.000 3 2013 2019
Metastasis from malignant tumor of prostate
disease Neoplastic Process 342 18 0.030 None 1.000 3 1999 2020
CUI: C2363774
Disease: Neutrophilic asthma
Neutrophilic asthma
disease Disease or Syndrome 40 2 0.030 None 1.000 3 2017 2019
CUI: C2939094
Disease: Skin sensitisation
Skin sensitisation
disease Disease or Syndrome 34 0.030 None 1.000 3 2017 2018